Age, years (mean ± SD) | 61 ± 12 |
Female sex, n (%) | 22 (73%) |
BMI, kg/m2(mean ± SD) | 24.3 ± 2.7 |
Past medical history, n (%): | |
Active smoking | 14 (47%) |
Arterial hypertension | 9 (30%) |
Dyslipidemia | 4 (13%) |
Obesity (BMI >30 kg/m2) | 1 (3%) |
Diabetes mellitus | 0 (0%) |
Pheochromocytoma | 0 (0%) |
Thyroid disease (substituted hypothyroidism) | 1 (3%) |
Renal disease | 0 (0%) |
Liver disease | 0 (0%) |
Fisher grade (1/2/3/4), n (%) | 0 (0%)/3 (10%)/9 (30%)/18 (60%) |
WFNS score (1/2/3/4/5), n (%) | 12 (40%)/6 (20%)/3 (10%)/0 (0%)/9 (30%) |
Aneurysm position, n (%) | |
ICA | 7 (24%) |
MCA | 10 (33%) |
AComA/ACA | 10 (33%) |
VA/BA | 1 (3%) |
PCA/PComA | 2 (7%) |
Aneurysm treatment | |
Coiled, n (%) | 27 (90%) |
Craniotomy, n (%) | 3 (10%) |
Day of treatment, (mean ± SD) | 1.9 ± 0.7 |
ICU period, n (%): | |
Vasospasm | 14 (47%) |
Delayed cerebral ischemia | 8 (27%) |
Re-bleeding | 4 (13%) |
Hydrocephalus (derivated) | 16 (53%) |
Tracheostomy | 11 (37%) |
ICU length of stay, day (mean ± SD) | 16 ± 8 |
Level of glucose just before 18 F-FDG PET | 139 ± 4 |
(mg/dl, mean ± SD) |